| Company Name | Gynofem Healthcare & Pharmaceuticals LTD |
|---|---|
| Promoter | Nishi Kant Joshi |
| Est Year | 2016 |
| Industry | Healthcare - Pharmaceuticals |
| ISIN No | INE0NLL01017 |
| Face Value | ₹1 |
| Website Link | https://gynofemhealthcare.com/ |
Gynofem Healthcare Pvt Ltd. is a specialized pharmaceutical and healthcare company focusing on women's health. The company develops and markets a range of gynecological, fertility, and maternity care products.
Gynofem Healthcare has experienced steady revenue growth due to rising awareness about women's health and an increasing demand for gynecological treatments. The company has expanded its product portfolio and strengthened its presence in both domestic and international markets.
Women's healthcare is a fast-growing segment within the pharmaceutical industry. Investing in Gynofem Healthcare Pre-IPO shares provides exposure to a niche yet expanding healthcare market.
Growth in women's healthcare products, increasing focus on reproductive health, and strong government initiatives for maternal care.
Gynofem Healthcare is launching new fertility treatment solutions and forming strategic partnerships with global healthcare providers.
Gynofem Healthcare is advancing its gynecological product line by integrating biotechnological and chemical innovations to meet international standards and improve treatment outcomes.
With an eye on underserved regions, Gynofem Healthcare plans to extend its distribution network across tier 2 and tier 3 cities in North-Eastern India, strengthening its market presence.
